What factors influence your decision to continue or taper antipsychotics for behavioral symptoms of dementia after the acute phase resolves?
1 Answers
Mednet Member
Psychiatry · Stanford Medicine Child And Adolescent Psychiatry
With no FDA-recommended treatments for severe behavioral symptoms of dementia, the most recent American Psychiatric Association (APA) practice guidelines of 2016 continue to recommend antipsychotic drugs when medical and environmental factors have been tended to (Reuss et al., PMID 27133416). While ...